Serum superoxide dismutase activity in acute and chronic paediatric liver diseases

Background and study aims: Measuring serum superoxide dismutase (SOD) levels in infants and children having acute or chronic liver disease of different aetiologies, and correlating these levels with disease aetiology in an attempt to clarify the role of SOD as an antioxidant in these diseases. Patients and methods: We prospectively enrolled 58 infants and children and divided them into four groups: Group I, 24 patients with surgical cholestasis; group II, 11 patients with medical cholestasis; group III, nine patients with autoimmune chronic hepatitis; and group IV, 14 patients with viral hepatitis. Forty healthy age-and sex-matched children served as controls. Serum SOD activity was measured in all patients and controls using spectrophotometry. Results: The level of SOD showed a statistically significant increase in patients with medical cholestasis compared to healthy controls (p < 0.0001). SOD activity of other groups showed no significant difference compared to controls. Conclusions: Significantly increased serum SOD in infants and children with medical cholestasis is probably consequent to its increase in liver tissue in response to the liberation of reactive oxygen species. This suggests that products of free radical reactions might be involved in the pathogenesis and/or progression of medical cholestasis, and that SOD might attempt to minimise the liver injury. (C) 2014 Arab Journal of Gastroenterology. Published by Elsevier B.V. All rights reserved.